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Globin prepared from macaca mulatta monkey hemoglobin was separated
into　 α　and β-polypeptide　 chains　 by　 countercurrent　 distribution　 method.　 The
β-polypeptide　 chain　 was　 digested　 with　 trypsin.　 The　 insoluble　 tryptic　 peptide
(so-called　 β-core),　 the　 precipitate　 of　the　 digest　 at　pH　 6.4,　 was　 obtained　 by
centrifugation. This insoluble tryptic peptide after oxidized with performic 
acid was digested with pepsin or redigested with trypsin, and the amino
acid　 composition　 was　 examined.　 Next,　 the　 amino　 acid　 sequence　 of　 the β-core
containing 38 amino acid residues was determined by the DNP method, the 
PTC method, and the carboxypeptidase method. The result was compared
with　 the　 known　 sequence　 of　 the β-core　 of　 human　 hemoglobin.　 Between
these two hemoglobins, two amino acid substitutions were found; that is, 
the 5th and 22nd residues from the N-terminus are threonine and arginine 
in case of human hemoglobin, but glutamine and lysine, respectively in 
case of macaca mulatta monkey hemoglobin.
                  INTRODUCTION 
   Since DARWIN, classification and evolution of living organisms 
have been studied by comparative investigations on their shapes and 
habits. ANFINSEN, however, proposed to deduce the evolutional. process 
of genes which control protein synthesis, by comparing structures of 
proteins on molecular level,which play an important role in constitu-
tions and functions of living organisms. Since then a new branch called 
chemical paleogenetics has been noted. For elucidation of this branch, 
the sequences of the subunits of DNA which are codes in genes are 
necessary to be determined. At this stage that the determination of 
basic sequences of DNA is difficult, however, it is significant to get 
information on the primary structures of proteins which are the primary 
products of DNA, and to deduce the structure of DNA by the informa-
tion obtained.
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   For the structural study of proteins, hemoglobin is one of suitable 
materials because of its presence in most animals and easy isolation. 
It is also available because a living organism has several kinds of 
resembling hemoglobins so that it enables to deduce how they have 
evolved from the common origin. The primary structures of the a4) 15) 
and Q-polypeptide41, 24) chains of human hemoglobin and those of the 
a17) and i9-polypeptide271 chains of horse hemoglobin have already been 
determined. Besides them, pig,5),30) rabbit, 8),211 and sheep31 hemoglobins 
are being studied. The differentiating time of living organisms can 
be assumed by comparing these known primary structures of hemoglo-
bins. It is said that it takes 1 x 107 years to substitute one amino acid 
residue to another. 32) 
   The structural differences in abnormal hemoglobins are interesting 
problems of genetics especially because they are due to mutation. Since 
Hb M was discovered by HoRLEIN et al. ,13) many kinds of abnormal 
hemoglobins such as Hb S,22) Hb E, and so forth have been discovered 
and their primary structures determind. ZUCKERKANDL and PAULING34)35) 
took up abnormal hemoglobins as proteins during the molecular evolu-
tion or molecular disease. BEAL and LEHMAN21 studied on the correlation 
between abnormal hemoglobins and genetic code and presented the 
shema of one-step mutation of amino acids. They reported that most 
abnormal hemoglobins were due to one-step mutation although some 
could not be explained without double-step mutation. Recently, however, 
with the advance of studies on code, it is said that abnormal hemoglo-
bins are almost due to single base change. 
   From comparative biochemical interset in heridity and evolution, 
the present author chose, as the experimental material, hemoglobin 
from macaca mulatta monkey which evolutionally resembles man pretty 
well. 
   It was reported by ZUCKERKANDL and SCHROEDER36) that the amino 
acid composition of gorilla hemoglobin differed from human hemoglobin 
at one point in the a and Q polypeptide chains, respectively. BUETTNER-
JANUSH and H(LL6) demonstrated a pretty large difference in the amino 
acid composition of the 8-polypeptide chain between lemur fulvus and 
human hemoglobins. Concerning macaca mulatta monkey hemoglobin, 
since SCHAPIRA and K.RUCH25) reported its immunological resemblance to 
human hemoglobin, CABANNES and SEARAIN,7) RODNAN and EBAUGH23) 
showed the difference between these two hemoglobins by paper chroma-
tography. FINE et al.") observed the similarity by agar gel electroph-
oresis, but ZUCKERKANDL el al.3`1) found a slight difference by finger-
printing method. According to MATSUDA and MAITA,18) the N-terminal 
structures of both the a and Q-polypeptide chains of nzacaca mulatta 
monkey hemoglobin were respectively Val-Leu and Val-His-Leu, which 
are exactly the same as those of human hemoglhbin. SHIKAYA26) clearly
demonstrated the difference between macaca mulatta monkey and human 
hemoglobins by using such techniques as agar gel electrophoresis, 
cellulose acetate membrane electrophoresis, CM cellulose column chro-
matography, alkaline denaturation, and finger-printing method. MAITA"' 
investigated the amino acid compositions of the tryptic peptides soluble 
at pH 6.4 of the a-polypeptide chain in mmmacaca mulatta monkey hemoglo-
bin and deduced that it differed from human hemoglodin at five points 
among 101 amino acid residues. Similarly, TAKEI28' discovered six 
differences among 108 amino acid residues of the 9 poly pedtide chain. 
Successively, IGAWA, 14) by the sequence determination of 60 amino acid 
residues of the soluble tryptic peptides of the a-polypeptide chain in 
macaca mulatta monkey hemoglobin, found two differences between these 
two hemoglobins. MATSUDA et a1.19' determined the whole amino acid 
sequence of the soluble tryptic peptides of the p-polypeptide chain and 
discovered six amino acid substitutions between human and macaca 
mulatta monkey hemoglobins. Their findings agree with TAKEI 's report 18) 
on the amino acid composition. The present author, by using various 
kinds of techniques, determined the amino acid composition and seque-
nce of the insoluble tryptic peptide (so-called core) of the Q-polypeptide 
chain in macaca mulatta monkey hemoglobin. 
              MATERIALS AND METHODS 
1) Preparation of the Q-Polypeptide Chain from Macaca mulatta Monkey 
 Hemoglobin 
   Blood was obtained from abdominal aorta of macaca mulatta monkey. 
According to DRABKIN' S method, 9' hemoglobin was prepared. It was 
removed the heme by ANSON and MIRSKY' S method.') Globin thus 
prepared was separated into a and ,8-polypeptide chains by counter-
current distribution method20' with the system of sec-butanol containing 
0.86% trichloroacetic acid, propionic acid, and water (8.7:1.5:11.0, 
v/v). The solution containing the Q-polypeptide chain was transferred 
in a visking tube 24/32, dialyzed agail~st deionized water, and lyophili-
zed after the organic solvent in the solution was fully removed. 
2) Preparation of the Insoluble Trypt is Peptide from the 18-polypeptide 
 Chain 
   The i9-polypeptide chain (2g) dissolved in 100ml of 8M urea was 
denatured by stirring at 60°C for 45 min. It was dialyzed against more 
than 20 changes of 31 of deionized water overnight for complete removal 
of urea. The urea-denatured (9-polypeptide chain, after adjusted to pH 
8.5 with 0.1 N NaOH, was digested at 37°C for 4 hours with 20mg of 
trypsin (Worthington Biochemical Corporation, twice crystallyzed). 
The pH of the digest maintained at 8.5 with 0.1N NaOH. After the
digestion ceased, the solution stirred and adjusted to pH 6.4 by adding 
0.1 N acetic acid was allowed to stand overnight at 0°C in a low 
temperature room, and then the pH was measured and readjusted to 
pH 6.4 precisely. The insoluble tryptic peptide (so-called core), which 
was precipitated at pH 6.4, was isolated by cold centrifugation (9000 
r.p.m. x45 min.). 
3) Oxidation of the Insoluble Tryptic Peptide with Performic Acid. 
   The insoluble tryptic peptide (Ca 400mg) was oxidized with per-
formic acid. Performic acid used was prepared by mixing 18 ml of 
99% formic acid and 2ml of 30% hydrogen peroxide in a round-bottomed 
flask with an interchangeable ground glass joint, which was sealed 
perfectly and allowed to stand at room temperature for 2 hours. Later, 
the performic acid solution thus prepared was cooled to be 0°C. Sub-
sequently, the insoluble tryptic peptide dissolved in 5ml of formic acid 
cooled at 0°C was oxidized at 0°C for 2 hours with 20m1 of performic 
acid. The reaction was stopped by adding 100rn1 of deionized water. 
The performic acid-oxidized insoluble tryptic peptide was dried in a 
rotary evaporator below 37°C for removal of performic acid. 
4) Digestion of the Oxidized Insoluble Tryptic Peptide with Pepsin 
   The insoluble tryptic peptide (a-core) dissolved in 50ml of deionzied 
water and adjusted to pH 2.0 with 1N HC1 was digested with 4mg of 
pepsin dissolved in lml of 1/16N HC1. Pepsin, three time crystallized, 
was obtained from Sigma Chemical Company. The digestion was stopped 
by adjusting the solution to pH 9.0 with MN NaOH. 
5) Column Chromatography of the Peptic Peptides from Insoluble 
 Tryptic Peptide 
   The resin (Dowex 1 x 2, Dow Chemical Company, 200-400 mesh) 
was washed with 1N NH, OH, deionized water, glacial acetic acid, and 
deionized water, successively, suspended in the starting buffer, and 
thoroughly evacuated. It was packed in a column (2 x 150cm) , which 
was fully equilibrated by pouring the starting buffer (Ca 41"'. To this 
column was applied 30m1 of the peptic digest solution which was adju-
sted to pH 9.5 by adding IN T',TaOH. Acetate buffer (the starting 
buffer), pH 8.5, containing 1% pyridine, 1% picoline, and 1% collidine 
was used as the first developer. During the development, the column 
was warmed at 37°C and the flow rate was 160m1 per hour. The first 
11 fractions were developed with the starting buffer and thereafter the 
gradient elution was employed, that is, the development between 
Fractions No. 12-150 was carried out by supplying 0.1N acetic acid in 
the upper chamber to 1 liter of the starting buffer in the mixing cham-
ber, and from Fraction No. 241 to 270, the content of the upper 
chamber was changed into 1N acetic acid. The column was finally 
washed with glacial acetic acid. All the organic bases used had been 
purified by distillation and deionized water decarbonized and thoroughly 
evacuated. A eluate was collected in 10 ml-fractions by a fraction 
collector. The 0.5m1 portion of individual fractions was subjected to 
ninhydrin reaction according to YEMM and C>CI:ING. ,3>> The ninhydrin-
positive fractions were combined respectively, dried under reduced 
pressure below 37°C, redissolved in 5m1 of deionized water, and finally 
lyophilized. 
6) Redigestion of the Insoluble Tryptic Peptide with Trypsin in 1M 
 NH4 OH 
   The performic acid-oxidized insoluble tryptic peptide (i.` -core), Ca 
300m g, was dissolved in 3m1 of 1M NH4 OH at 0°C, stirred, and 
adjusted to pH 9.0 with 1N acetic acid. Redigestion was carried out 
at 0°C for 7 hours with 3mg of trypsin (Worthington Biochemical 
Corporation, Twice cystallized). The digest was dried in a rotary 
evaporator for removal of ammonia. All the operations described above 
were carried out in a low temperature room (0°C) . The pH of the 
solution was not adjusted during digestion, but was 8.7 after 7 hour 
digestion. 
7) Column Chromatography of Tryptic Peptides from the Oxidized 
 Insoluble Tryptic Pepside 
   Peptides produced by the Cryptic redigestion of the insoluble tryptic 
peptide (/9-core) were isolated by column chromatography. Resin used 
was Dowex 1 x 2 and a column was 1 x 60 cm. Tryptic peptides, after 
dissolved in 10 ml of deionized water and adjusted to pH 9.5 with 1 N 
NaOH, were applied to the column. Starting buffer was acetate buffer, 
pH 8.5, containing 4% pyridine and 1% picoline. Developmet nt was 
carried out at the flow rate of 60-70 ml per hour, the column being 
kept at 37°C. The first 10 fractions were developed with the starting 
buffer and thereafter gradient elution was employed;that is, from 
Fraction No. 11 to 67, acetate buffer, pH 5.0, containing 4% pyridine 
and 1% picoline in the upper chamber was fed into 500 ml of the 
starting buffer in the mixing chamber, and from Fraction No. 68 to 100, 
the content in the upper chamber was IN acetic acid. 10 ml-fractions 
were collected by a fraction collector and treated in the same way as 
the peptic peptides described previously. 
8) Paper Chromatography of Various Peptides from the Insoluble 
 Tryptic Peptide
   The peptides isolated by column chromatography were again 
isolated and purified by paper chromatography. Descending method 
was employed on a sheet of Toyo Filter Paper No. 51 with the upper 
phase of the mixture of n-butanol, glacial acetic acid, and deionized 
water (4:1:5). The peptides were located by spraying with 2% ninhy-
drin-n-butanol solution and heating to color with an iron, Besides, 
location of the peptides which contained histidine was performed by 
PnuLI's reaction. The peptides were eluted from paper with 5% acetic 
acid. 
9) Digestion of the Peptic Peptides with Chymotrypsin and Isolation 
 of Chymotryptic Peptides by Paper Chromatography 
   Ca 2.0 .moles of individual peptides, after dissolved in 5 ml of 
deionized water and adjusted to pH 8.0 was digested at 37°C for 22 
hours with 2 mg of chymotrypsin (Sigma Chemical Co., 3 time crysta-
llized). During the beginning 8 hours, the pH was maintained at 8.0 
with 0.1N NH4OH, but was not adjusted after that. The digest was 
dried under reduced pressure and then dissolved in deionized water. 
The chymotryptic peptides were isolated and purified by descending 
paper chromatography with the mixture of n-butanol, glacial acetic 
acid, deionized water (4:1:5). Elution was performed with 5% acetic 
acid. 
10) Paper Electrophoresis of the Peptides 
   Electric charge of individual peptides was examined by high voltage 
paper electrophoresis in order to distinguish between aspartic acid and 
asparagine, and between glutamic acid and glutamine. 
   A sample was applied on near the center of a sheet of Toyo Filter 
Paper No. 51 (10 x 60cm). Electrophoresis was carried out at 2 KV for 
2 hours in pyridine acetate buffer, pH 6.4 (pyridine: glacial acetic 
acid: deionized water=100:4:900) by hanging the paper in an electro-
phoretic apparatus (Ishidai type). Detection of the peptides was per-
formed by ninhydrin reaction as in case of paper chromatography. 
11) The N-Terminal Amino Acid Analyses of the Peptides by the DNP 
 Method 
   Dinitrophenylation of the peptides was performed in 1% NaHCO3 
solution. A peptide (0.2 - 0.5 imole) was dissolved in 3m1 of 1% NaHCO3, 
and to this was added 0.05 ml of 2. 4-dinitro-l-fluorobenzene (DNFB). 
The reaction was carried out at 40°C for 2 hours. After the reaction 
was stopped, the excess of DNFB was extracted. The aqueous phase, 
after dried and redissolved in 4 ml of constant boiling point HCl, was 
hydrolyzed at 105°C for 16 hours in a sealed tube. The N-terminal
DNP-amino acid was extracted with three 10ml-portions of ether from 
the hydrolysate. The ether phase transferred in a heart-shaped flask, 
a modification of MILLS' apparatus, was dried under reduced pressure. 
The flask was then fixed to a cold finger and evacuated by a vacuum 
pump in order to remove as much dinitrophenol as possible. Two 
dimensional paper chromatography was employed for identification of 
the DNP-amino acids. On a sheet of Toyo Filter Paper, ascending me-
thod was performed by using n-butanol saturated with 1N NH, OH for 
the first dimension and 0.5M phosphate buffer for the second dimens-
ion. 
12) The PTC Method for Amino Acid Sequence Analyses of the Pep-
 tides 
   Phenylisothiocyanation of the peptides was carried out according 
to a modification of EDMAN original method.1°> , 111 For ring formation, 
trifluoroacetic acid was used .291 Analyses were performed by so-called 
elimination method, that is, by examining amino acid composition of 
the remaining peptide after each stage of the PTC method. 
   Peptide solution (0.5-2.0 Imole), after dried under reduced pres-
sure in a heart-shaped flask of MILLS' apparatus, was dissolved in 
2.5m1 of 66% pyridine and to this was added 0.05ml of phenylisothio-
cyanate (PTC) obtained from Hayashi Pure Chemical Industry Ltd. 
In case the pH of this mixture was below 7.5, it was brought to pH 
7.5 with 0.1N NH4 OH . The mixture was incubated at 37°C for 3 hours. 
After reaction stopped, the reaction mixture was dried under reduced 
pressure below 37°C and evacuated for 30 min. by a vacuum pump, 
the flask being fixed to MILLS' apparatus. After that, in order to 
perform ring formation, the mixture was added 1ml of trifluoroacetic 
acid and allowed to stand at room temperature for 4 hours. After 
reaction stopped, trifluoroacetic acid was removed under reduced pres-
sure. The residue dissolved in 3ml of deionized water was extracted 
with four 3ml-portions of benzene. By this treatment, the resultant 
PTH-amino acids were extracted in the benzene phase and the peptide 
lacking one N-terminal residue of the original peptide remained in the 
aqueous phase. A portion of the aqueous phase was dried and hyd-
rolyzed with constant boiling point HCl for 24 hours. The amino acid 
composition was examined and compared with that of the peptide before 
subjected to the PTC method. The remainder of the aqueous phase 
after dried was used in the next stage of the PTC method. 
13) The C-Terminal Amino Acid Analyses of the Peptides by Carb-
 oxypeptidase A Method 
   In 0.5 ml of 10% Licl solution, 0.01ml of carboxypeptidase A 
(Sigma Chemical Co., 50 mg/ml toluol water suspension) was dissolved,
A sample (0-5-1.0 pmole) in a heart-shaped flask was dissolved in 2 
ml. of borate buffer, pH 8.1, and to this was added 0.5 ml of carboxy-
peptidase A solution prepared as above. Digestion was performed 
at 37°C for the appropriate time and then in order to stop enzymatic 
reaction, the reaction mixture was added several drops of glacial acetic 
acid. The digest dried under reduced pressure below 37°C was subje-
cted to amino acid analysis. 
   Borate buffer was prepared as follows; in 100 ml of 1N NaOH, 
12.404g of H3BO,, was dissolved and to this was added deionized water 
so that the volume was 1 liter. This solution was further adjusted 
to pH 8.1 witn 0.1N HC1. It was diluted ten times when used. 
14) Amino Acid Analyses of the Peptides 
   Amino acid compositions of the purified peptides and the remaining 
peptides after the PTC method were determined after they were com-
pletely hydrolyzed with HC1. 
   Peptides dissolved in 4m1 of constant boiling point HCl were hydr-
olyzed at 105°C for 24 hours in a sealed tube. Dried hydrolysates, after 
redissolved in a small portion of deionized water and again dried for 
removal of HC1, were subjected to an amino acid analyzer, Hitachi 
KLA 2 for the amino acid analyses. 
              RESULTS AND DISCUSSION 
1) Determination of the N-Terminal Amino Acid of the Insoluble 
 Tryptic Peptide by the DNP Method 
   The N-terminal amino acid of the insoludle tryptic peptide was 
known to be glycine by the DNP method. It was also confirmed by the 
comparison with that of human hemoglobin. Hydrolysis was therefore 
carried out only for 10 hours for keeping out destruction of DNP-
glycine as minimal as possible. 
2) Amino Acid Sequences of the Peptic Peptides from the Insoludle 
  Tryptid Peptide, QT10, 11, 12 of the j3-chain in Macaca mulatta Monkey 
  Hemoglobin 
   The insoluble tryptic peptide after oxidized with performic acid 
was digested with pepsin at pH 2.0 for 8 hours at 37°C. The digest 
was isolated by Dowex 1 x 2 column chromatography and purified by 
paper chromatography. Fig. 1 and Fig. 2 show the column and paper 
chromatograms. As shown in Fig.1, eight main peptides and some other 
peptides whose amounts of yield were very small. Amino acid comp-
ositions of these eight main peptides were examined and the results 
are given in Table I ,.
                               Fraction number 
Fig. 1 Column chromatography of peptic peptides from the insoluble tryptic 
         peptide, IT10, 11, 12 of the Q-chain in macaca mulatta monkey hemoglobin
          Lys His Arg S03 Asp Thr Ser Glu Pro Gly~!Ala ValMet Leu'ITyr Phe Try Total 
 PI-a 1.00, 1.23 10.93 1.01 12,98 10,84 8 
 PIN-a 1.15';1.98 1.00 0.921.151.78 11.21 0.82 10 
 PIII-b 0.95 1.01 1.04 3 
 PIV-a 0.84 0.88 1.021 3.23 6 
 PVI-a 0.97 1.03 ! '1.00! 3 
 PVIII-a 0.92'1.07 I1.00i0.99 1.00 5 
 PIX-a 0.93;1.06 I1.00~1.07 0.811.04 1 2.05 8 
 PX-a (1.00 2.04 1.051.15 10.741 6 
    Table I Amino acid compositions of peptic peptides from the insoluble tryptic 
               peptide LIT10. 11. 12 of the 8 chain in macaca mulatta monkey hemglobin
   Subsequently, the amino acid sequences of individual peptides were 
determined by the DNP, PTC, and carboxypeptidase methods. 
a) PI-a eluted at pH 8.4 Rf Leu 1.00 
   Three stages of the PTC method were performed. 
 Stage 1 Phe 0.00 Lys 1.00 Leu 3.11 Asp 0.91 Gly 1.07 Val 0.88 
 Stage 2 Phe 0,00 Lys 0.00 Leu 3,00 Asp 1.06 Gly 1.00 Val 0.90
    Fig 2 Paper chromatography of peptic peptides from the insoluble tryptic peptide, 
              QT10, 11, 12 of the R-chain in macaca mulatta monkey hemoglobin
 Stage 3 Phe 0.00 Lys 0.00 Leu 2.11 Asp 1.06 Gly 1.00 Val 0.90 
   This peptide was known basic by high voltage paper electroph-
oresis. This indicates that the residue presented as Asp in the analysis 
is asparagine. The sequence of this peptide was, therefore, Phe-Lys-Leu 
CLeu 2, Asp (NH,,) 1, Gly 1, Val, 1D. As shown in Table I, the 
composition of the C-terminal region of this fragment including the 
third residue from its N-terminus accords with that of P IV-a, which 
therefore the subject of the next analysis. 
b) PIV-a eluted at pH 6.3 Rf Leu 1.15 
   The N-terminal residue was leucine by the DNP method. This 
peptide was neutral, confirming the presence of asparagine. Therefore, 
PIV-a was deduced to be a peptide positioned next to lycine of PI-a at 
the C-terminal side. The yield of PI-a was lower than other peptide, 
whereas that of PIV-a was higher. This fact enabled to confirm that 
PIV-a overlapped PI-a as mentioned above. The peptide containing one 
residue each of phenylalanine and lysine must have been discovered 
but such a peptide could not be detected from any part of paper chro-
matogram. Four stages of the PTC method were carried ont on PIV-a. 
 Stage 1 Leu 2.04 Gly 0.96 Asp 0.94 Val 1.03 
 Stage 2 Leu 1.20 Gly 0.87 Asp 0.99 Val 0.92 
 Stage 3 Leu 1.16 Gly 0.22 Asp 0,98 Val 0.84 
 Stage 4 Leu 1.16 Gly 0.10 Asp 0.23 Val 0.83 
   PIV-a (0.5 umole) was further subjected to carboxypeptidase me-
thod. By 30 minute digestion, 0.325 pmole of leucine and 0.16 pmole 
of valine were obtained. This indicates that the C-terminal residue of
this peptide was leucine. Therefore, the amino acid sequence of PIV-a 
was determined as follows; 
     Leu-Leu-Gly-Asp(NHZ)-Val-Leu 
     D.P P P P C 
   By combining the above-mentioned results, the sequence of PI-a 
was determined as follows;
c) PIII-a eluted at pH 6.4 Rf Leu 0.22 
   The N-terminal residue was known to be valine by the DNP me-
thod. This peptide was digested with chymotrypsin at pH 8.0 for 22 
hours at 37°C. Three peptide fragments were isolated from the digest 
by paper chromatogrphy. They were designated PIIIa-chy-1, PIIIa-chy-
2, and PIIIa-chy-3 in the order of their Rf Leu values from the hig-
hest. 
 PIIIa-chy-1 Rf Leu 1.00 
   Composition: Val 1.96, Cys 1.00, Leu 1.03 
 Three stages of the PTC method were carried out. 
 Stage 1 Val 1.01 Cys 1.00 Leu 0.98 
 Stage 2 Val 1.00 Cys 0.00 Leu 0.99 
 Stage 3 Val 0.20 Cys 0.00 Leu 1.00 
  The sequence was, therefore, Val-Cys-Val-Leu. 
 PIIIa-chy-2 Rf Leu 0.30 
   Composition: Ala 1.16, His 1.93, Phe 0.90 
 Stage 1 Ala 0.16 His 2.06 Phe 0.93 
 Stage 2 Ala 0.00 His 1.00 Phe 1.00 
 Stage 3 Ala 0.00 His 0.00 Phe 1.00 
 From the above result, the sequence was determined to be Ala-His-
 His-Phe. 
 PIIIa-chy-3 Rf Leu 0.13 
   Composition: Gly 1.21, Lys 0.78 
 Stage 1 Gly 0.30 Lys 1.00 
   The sequence was therefore, Gly-Lys.
   Since the N-terminal residue of PIII-a had already been known to 
be valine, PIIIa-chy-1 appears to be the N-terminal peptide of P-IIIa, 
There could be found no peptic peptides in which lysine was positioned 
at the C-terminus except PIIIa-chy-3. Therefore ., PIIIa-chy-3 was decided 
to be the C-terminal peptide not only of PIII-a but also of the insoluble 
tryptic peptide. 
   By putting the above-mentioned results together, the amino acid 
sequence of PIII-a was determined as follows;
d) PIII-b eluted at pH 6.4 Rf Leu 0.7 
   Two stages of the PTC method were carried out. 
 Stage 1 Ala 0.15 Glu 0.98 Leu 1.02 
 Stage 2 Ala 0.00 Glu 0.25 Leu 1.00 
   The result of high voltage paper electrophoresis showed this peptide 
was neutral, confirming the presence of glutamine. The sequence was, 
therefore, determined to be Ala-Glu (NH2)-Leu. 
e) PVI-a eluted at pH 5.9 Rf Leu 0.7 
   Two stages of the PTC method were performed. 
 Stage 1 Gly 0.23 Thr 1.03 Phe 0.97 
 Stage 2 Glp 0.00 Thr 0.11 Phe 1.00 
   Since there could be found no peptic peptides whose N-terminal 
residue was glycine except this peptide, it was decided to be the N-
terminal peptide of the 8-core. 
f) PVIII-a eluted at pH 4.4 Rf Leu 0.25 
   By the DNP method, the N-terminal amino acid residue was known 
to be histidine. Further analysis was not performed because this pe-
ptide was known to be identical with PIXa-p-3 of PIX-a. 
g) PIX-a eluted at pH 3.8 Rf Leu 0.31 
   The N-terminal residue was serine as a result of the DNP method. 
This peptide (30 umoles) was digested with 2mg of pepsin at pH 2.0 
for 22 hours at 37°C. Three peptide fragments were isolated from the 
digest by paper chromatography. They were designated PIXa-p-1, 
PIXa-p-2, and PIXa-p-3 in the order of their Rf Leu values from the 
lowest. The amino acid seauence of each fragment 'was determined in
the following procedure. 
 PIXa-p-1 Rf Leu 0.20 
   Composition: His 0.91, Cys 1.00, Asp 1.09, Lys 0.85, Leu 1.13 
 Three stages of the PTC method were carried out. 
 Stage 1 His 0.00 Cys 1.00 Asp 1.06 Lys 1.00 Leu 0.93 
 Stage 2 His 0.00 Cys 0.00 Asp 0.98 Lys 1.00 Leu 1.01 
 Stage 3 His 0.00 Cys 0.00 Asp 0.25 Lys 1.00 Leu 1.00 
   This peptide after Stage 2 was known to be neutral by high voltage 
paper electrophoresis. This indicates that the amino acid presented as 
Asp in the analysis was aspartic acid. The sequence was, therefore, 
His-Cys-Asp-(Lys, Leu). 
 PIXa-p-2 Rf Leu 0.29 
   Composition: Lys 1.00, His 1.00, Cys 1.00, Asp 0.94, Ser 0.70, 
               Glu 1.04, Leu 2.30 
   Since the composition of this peptide accorded with that of PIX-a, 
it seemed an indigested peptide. Carboxypeptidase method was carried 
out on this peptide and the C-terminal amino acid residue was known 
to be leucine, namely, it was digested at 37°C for 8 hours and subje-
cted to amino acid analysis. Leucine was only recognized. 
  PIXa-p-3 Rf Leu 0.87 
   Composition: Ser 0.90, Glu 1.03, Leu 1.06 
   Two stages of the PTC method were carried out. 
 Stage 1 Ser 0.00 Glu 0.94 Leu 1.05 
 Stage 2 Ser 0.00 Glu 0.18 Leu 1.00 
   Thia peptide was acidic as a result of high voltage paper electro-
phoresis, indicating the presence of glutamic acid. The sequence was, 
therefore, Ser-Glu-Leu. 
   The sequence of PIX-a peptide was determined as follows by com-
bining the above-mentioned results together.
h) PX-a eluted at pH 3.7 Rf Leu 0.22 
   The C-terminal' amino acid residue of this peptide was known to be 
asparagine by the carboxypeptidase method. Namely, the amino acid 
analysis of the digest with carboxypeptidase at 37`'C for 75 min. gave 
asparagine alone. Four stages of the PTC method were carried out.
 Stage 1 His 0.00 Val 0.93 Asp 1.96 Pro 1.12 Glu 1.00 
 Stage 2 His 0.00 Val 0.15 Asp 2.00 Pro 1.08 Glu 0.90 
 Stage 3 His 0.00 Val 0.00 Asp 1.22 Pro 0.97 Glu 0.95 
 Stage 4 His 0.00 Val 0.00 Asp 1.04 Pro 0.00 Glu 0.95 
   According to the result obtained by high voltage paper electro-
phoresis, this peptide was acidic. It was again subjected to high vol-
tage paper electrophoresis after Stage 2. Its mobility was -2. There-
fore, among the two residues presented as Asp and one residue as 
Glu, two residues were deduced to be acidic amino acids. However, 
since the C-terminal residue had been known to be Asp (NH,), the 
following sequence was determined. 
 His-Val-Asp-Pro-Glu-Asp (NH,). 
E 
  p p p p c
3) Amino Acid Compositions of Redigested Peptides with Trypsin 
 from the Oxidized a-Core 
   In order to determine the whole amino acid sequence of the insolu-
ble tryptic peptide, the performic acid-oxidized insoluble tryptic peptide
                              Fraction number 
Fig. 3 Column chromatography of the tryptic peptides from the oxidized 8-core
was redigested with trypsin (0.01%) at 0°C for 7 hours in 1M NH, OH 
solution. The digest was isolated by Dowex 1 x 2 column chromatogra-
phy and purified by paper chromatography. The column chromatogram 
and the paper chromatogram are given in Fig. 3 and Fig. 4, respecti-
vely.
      Fig. 4 Paper chromatography of the tryptic peptides from the oxidized 8-core 
   As shown in Fig. 4, two main peptides and several whose yields 
were very little were obtained. The amino acid compositions of these 
two peptides were analyzed and shown in Table II.
         Lys His Arg S03 lAsp Thr j Ser IGlu Pro 'Gly Ala Val Met Leu Tyr Phe Try Total 
TIV-a 1.231.76 1.000.98 I 1.891.33'2.65 4.24 0.99~, 16 
TVI- a 2.211.99 1.00 2.94 0.931.013.261.25 0.951.03 i 0.89 3.25 1.81 22 
TVIa-1 1.2810.7 1.981.27 0.96 1.14 0.64 9 
TVIa-2 1.010.81 1.0010.96'0.961.012.26 0.961.00 2.25 0.81 13
    Table II Amino acid compositions of the tryptic peptides from the oxidized -core 
a) TVI-a luted at pH 5.5 Rf Leu 0.66 
   The N-terminal was known to be glycine by the DNP method. This 
peptide was redigested with trypsin at 0°C for 5 hours in 1M NH4OH 
solution and the digest was subjected to paper chromatography. As a 
result, two distinct ninhydrin-positive spots were observed. They were
designated TVIa-1 and `I VIa-2, respectively in the order of the Rf value 
from the lowest. 
 TVIa-1 
   The amino acid composition of this peptide was Lys 1.28, His 
0.71, Asp 1.98, Glu 1.27, Pro, 1.00 Val 0.96, Leu 1.14, and Phe 0.64. 
This peptide was first subjected to the DNP method. The N-terminal 
residue was known to be leucine. 
 TVIa-2 
   The composition of this peptide was Lys 1.01, His 0.81, Cys 1.00, 
Asp 0.96, Thr 0.96, Ser, 1.01, Glu 2.26: Gly 0.96, Ala 1.00, Leu 
2.25, and Phe 0.81. According to the result of the DNP method, the 
N-terminal amino acid was glycine. This may indicate that this pepti-
de is located at the N-terminus of the 13-core. 
   In comparison of mac~xca mulatta monkey hemoglobin with human 
hemoglobin, this TVIa-2 appears to correspond to the peptide BRAUNI-
TZER et al. called i9T10+11, and there are two amino acid substitutions 
between these two peptides in their amino acid compositions. 
b) TIV-a eluted at pH 5.8 Rf Leu 0.76 
   The N-terminal amino acid residue of this peptide was known to 
be leucine by the DNP method. Compared with human hemoglobin, 
this peptide had the same composition with ,9T12 of human hemoglobin. 
4) Whole Amino Acid Sequence of the Insoluble Tryptic Peptide 9T10, 
 11, 12 (9-Core) 
   By combining two series of the results, that is, the amino acid 
sequences of the peptic peptides (PI-a, PIII-a, P111-b, PVI-a, PIX-a, 
and PX-a) and the amino acid compositions and the N-terminal analyses 
of the trypsin-redigested peptides (TIV-a, TVI-a, TVIa-1, TVIa-2), 
                                              TVI - a (IT10+11)




Gly - Thr - Phe - Ala - Glu(NH2) - Leu - Ser - Glu - Leu - His - Cys - Asp - Lys - Leu - His - Val - Asp - Pro - Glu --9 -> --4 --4 -3 -3 -9 E-- -y -9 - -> 
 P P P P D.P P P .P P C P P P P 
C 
   PVI - a PIII - b PIXa - p - I PIXa - p - 3(PVIII-a) pX - a 
                                            PIX - a (PIXa - p - 2) 
                                                             TIV - a (8T12) 
          (Arg) D~ , 
Asp (NH2) - Phe - Lys - Leu - Leu - Gly - Asp (NH2) - Val - Leu - Val - Cys - Val - Leu - Ala - His - His - Phe - Gly - Lys 
  C P P P P P P C D.P P P P P P P 
                              PIV - a PIIIa -chy-1 PIIIa - chy - 2 PIIIa-chy                                                                                                                                                              -3 
                         PI - a PIII - a
Fig. 5 Amino acid sequence of the insoluble tryptic peptide (3T10,11,12 from the 
         j3-polypeptide chain of macace. rnulatta monkey hemoglobin
the amino acid sequence of the 9-core was determined as shown in 
Fig. 5. 
   This sequence was compared with the known sequence of the 
corresponding peptide of human hemoglobin. Two amino acid substi-
tutions were found between them, that is, the 5th and the 22nd resi-
dues from the N-terminus are threonine and arginine in case of human 
hemoglobin, whereas they are glutamine and lysine, respectively in 
case of macaca mulatta monkey hemoglobin. The substitution at the 22nd 
residue is seen between gorilla and human hemoglobin s331. Further-
more, on viewing these amino acid substitutions from the triplet code 
suggested by NIRENBERG and OOHOA, the results given in Table III 
were obtained.
     Amino acid Genetic code 
Monkey Lys AAA AGA 
Human Arg AGA AGG CGA CGG CGC CGU 
Monkey Glu (NH2) CAA CAG 
Human Thr ACA ACG ACC ACU 
    Table III The relation between the amino acid substitution and triplet code
   As shown in Table III, the substitution, Arg-)Lys is due to single 
base change, however, Thr-Glu ("NH,,) is due to double base change. 
This fact seems very interesting when considered together with the 
fact that the abnormal hemoglobin so far discovered are all due to 
single base change. 
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